Drug Shortage Report for TEVA-CLOPIDOGREL
Report ID | 153733 |
Drug Identification Number | 02293161 |
Brand name | TEVA-CLOPIDOGREL |
Common or Proper name | TEVA-CLOPIDOGREL 75MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLOPIDOGREL |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-27 |
Estimated end date | 2022-12-10 |
Actual end date | 2022-11-11 |
Shortage status | Resolved |
Updated date | 2022-11-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v31 | 2022-11-12 | English | Compare |
v30 | 2022-11-11 | French | Compare |
v29 | 2022-11-11 | English | Compare |
v28 | 2022-10-28 | French | Compare |
v27 | 2022-10-28 | English | Compare |
v26 | 2022-09-30 | French | Compare |
v25 | 2022-09-30 | English | Compare |
v24 | 2022-09-07 | French | Compare |
v22 | 2022-09-07 | English | Compare |
v23 | 2022-09-07 | English | Compare |
v21 | 2022-08-18 | French | Compare |
v20 | 2022-08-18 | English | Compare |
v19 | 2022-08-15 | French | Compare |
v18 | 2022-08-15 | English | Compare |
v17 | 2022-06-30 | French | Compare |
v16 | 2022-06-30 | English | Compare |
v15 | 2022-06-16 | French | Compare |
v14 | 2022-06-16 | English | Compare |
v13 | 2022-05-24 | French | Compare |
v12 | 2022-05-24 | English | Compare |